Vindico Pharma Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $13M

Vindico Pharma General Information

Description

Developer of nanometer-scale particulate technologies intended for a wide range of medical diagnostic and therapeutic applications. The company is dedicated to the discovery, development, and commercialization of highly innovative products, enabling healthcare providers to advance and improve their standard of patient care

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • A169, ASTeCC
  • University of Kentucky
  • Lexington, KY 40506
  • United States
+1 (267)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • A169, ASTeCC
  • University of Kentucky
  • Lexington, KY 40506
  • United States
+1 (267)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vindico Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 10-Oct-2016 $13M Completed Generating Revenue
3. Seed Round 25-Feb-2015 Completed Generating Revenue
2. Grant 01-Jan-2011 $900K Completed Generating Revenue
1. Grant 07-Apr-2010 $200K Completed Startup
To view Vindico Pharma’s complete valuation and funding history, request access »

Vindico Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nanometer-scale particulate technologies intended for a wide range of medical diagnostic and therapeutic ap
Drug Discovery
Lexington, KY

South San Francisco, CA
 

Stockholm, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vindico Pharma Competitors (18)

One of Vindico Pharma’s 18 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
Biocon Formerly PE-Backed Bengaluru, India
Nevian Lifescience Corporate Backed or Acquired Dhaka, Bangladesh
Ability Pharma Private Equity-Backed Cerdanyola, Spain
You’re viewing 5 of 18 competitors. Get the full list »

Vindico Pharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
NIH Office of the Director Government
U.S. Department of Health and Human Services Government
To view Vindico Pharma’s complete investors history, request access »

Vindico Pharma FAQs

  • When was Vindico Pharma founded?

    Vindico Pharma was founded in 2007.

  • Where is Vindico Pharma headquartered?

    Vindico Pharma is headquartered in Lexington, KY.

  • What industry is Vindico Pharma in?

    Vindico Pharma’s primary industry is Drug Discovery.

  • Is Vindico Pharma a private or public company?

    Vindico Pharma is a Private company.

  • What is the current valuation of Vindico Pharma?

    The current valuation of Vindico Pharma is .

  • What is Vindico Pharma’s current revenue?

    The current revenue for Vindico Pharma is .

  • How much funding has Vindico Pharma raised over time?

    Vindico Pharma has raised $1.28M.

  • Who are Vindico Pharma’s investors?

    NIH Office of the Director and U.S. Department of Health and Human Services have invested in Vindico Pharma.

  • Who are Vindico Pharma’s competitors?

    Genentech, Gesynta Pharma, Biocon, Nevian Lifescience, and Ability Pharma are some of the 18 competitors of Vindico Pharma.

  • When was Vindico Pharma acquired?

    Vindico Pharma was acquired on 10-Oct-2016.

  • Who acquired Vindico Pharma?

    Vindico Pharma was acquired by Poseida Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process